Activators of KCTD16 engage in diverse mechanisms to elevate its functional activity. One class of activators functions by increasing intracellular cAMP levels, an effect that can enhance the activity of cyclic nucleotide-gated channels, which KCTD16 may influence. When cAMP levels rise, not only do these channels become more active, but the overall cellular environment shifts, potentially altering KCTD16's regulatory effects on ion channel activity. Additionally, certain activators potentiate the activity of large conductance calcium-activated potassium channels, which could impact the function of KCTD16 if it is implicated in the modulation or association with these channels. This interaction may extend to other ion channels, where KCTD16's function could be potentiated by shifting its modulation to different channel types or by enhancing the channels it regulates.
Furthermore, other activators augment the function of various ion channels, including small conductance calcium-activated potassium channels and glycine receptors, which could indirectly enhance KCTD16's activity. In this context, KCTD16's role as a modulator becomes more pronounced with augmented channel function, potentially leading to an increased regulatory effect. Some activators are known to modulate ion channels nonspecifically, and their action may influence the activity of KCTD16 through complex interactions with the channels it associates with. By affecting the dynamics and function of these channels, these compounds indirectly elevate KCTD16's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which could phosphorylate proteins and modulate ion channels that KCTD16 interacts with, potentiating its function. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that penetrates cell membranes, raising intracellular cAMP and potentially impacting ion channels regulated by KCTD16. | ||||||
1-EBIO | 10045-45-1 | sc-201695 sc-201695A | 10 mg 50 mg | $87.00 $325.00 | 1 | |
Potentiates intermediate conductance calcium-activated potassium channels, possibly affecting channels that KCTD16 modulates. | ||||||
NS 1643 | 448895-37-2 | sc-204135 sc-204135A | 10 mg 50 mg | $123.00 $473.00 | 3 | |
Enhances the activity of large conductance calcium-activated potassium (BK) channels, potentially impacting the function of KCTD16 if it associates with these channels. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Augments the function of some glycine receptors, which if KCTD16 is a modulator, would indirectly increase its activity. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
A known blocker of several potassium channels that might indirectly enhance the activity of KCTD16 by shifting its modulation to other channels. | ||||||
Flufenamic acid | 530-78-9 | sc-205699 sc-205699A sc-205699B sc-205699C | 10 g 50 g 100 g 250 g | $27.00 $79.00 $154.00 $309.00 | 1 | |
Modulates various ion channels and could indirectly affect the activity of KCTD16 through modulation of associated potassium channels. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $46.00 $61.00 $117.00 $173.00 $530.00 | 36 | |
An ATP-sensitive potassium channel inhibitor that may indirectly increase the functional activity of KCTD16 by affecting associated channel dynamics. | ||||||